The expressions of THY1 and collagen III exhibited significant elevations in the NASH mice in comparison to the control group, while collagen I did not altered significantly (Figures 6I, J), suggesting the possibility of these genes serving as serum biomarkers to validate the severity of NAFLD. This evidence concerns the gene THY1 and metabolic dysfunction-associated steatotic liver disease.